Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2022

Genmab — Juni 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Peter_Panik
    wrote on sidst redigeret af
    #21

    Men håber på, at der atter fattes interesse for Genmab og kursen stryger til vejrs.

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #22

      Stadig interesse for ADC teknologien http://www.dacbiotech.com/en/show-132-196-1.html

      1 Reply Last reply
      0
      • G Offline
        G Offline
        Gasolin82
        wrote on sidst redigeret af
        #23

        Stockbull: Selvom Genmab vækster betydeligt, vil jeg ikke vurdere P/E som super lavt. Selskabet er ved at være modent ergo
        skal dem prissættes derefter.

        1 Reply Last reply
        0
        • G Offline
          G Offline
          Gasolin82
          wrote on sidst redigeret af
          #24

          *den

          1 Reply Last reply
          0
          • G Offline
            G Offline
            Gasolin82
            wrote on sidst redigeret af
            #25

            Et spænd mellem kurs 2000-4000 ville være perfekt. Så er der jo ingen downside risiko ved aktien?

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #26

              Ingen tvivl om,at der skeles mere og mere til P/E, når der handles i Genmab. Men der er stadig god grund til at handle i den høje ende med en forventet stor vækst og med eks. epcoritamab nærmere markedsføring.

              1 Reply Last reply
              0
              • D Offline
                D Offline
                deleted-user
                wrote on sidst redigeret af
                #27

                @Gasolin82 - Roche som er et modent selskab bruger ca. 20-25 % af indtægterne på RD. Genmab ligger lang tidligere i den cyklus, hvilket også afspejles i RD udgør 50 % af indtægterne. Blot for at have et pejlemærke.

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #28

                  USA/åbning: Solstrejf efter overskyet tirsdag
                  https://www.proinvestor.com/investornyt/831814/usa-abning-solstrejf-efter-overskyet-tirsdag

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #29

                    Onsdagens aktier: Mærsk til tops i usikkert, negativt marked
                    https://www.proinvestor.com/investornyt/831888/onsdagens-aktier-maersk-til-tops-i-usikkert-negativt-marked

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #30

                      Major Shareholder Announcement https://www.proinvestor.com/investornyt/831947/major-shareholder-announcement

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #31

                        Den nye aktionær med over 5%: https://www.wellington.com/en/

                        1 Reply Last reply
                        0
                        • MadsSkjernM Offline
                          MadsSkjernM Offline
                          MadsSkjern
                          wrote on sidst redigeret af
                          #32

                          Abbvie om epco https://twitter.com/bertrandbio/status/1532017882573459459?s=21&t=189vAgnCO369-t3SHoVu8g

                          1 Reply Last reply
                          0
                          • MadsSkjernM Offline
                            MadsSkjernM Offline
                            MadsSkjern
                            wrote on sidst redigeret af
                            #33

                            JnJ om darzalex: it’s gonna be our largest drug https://twitter.com/bertrandbio/status/1532009827899260931?s=21&t=189vAgnCO369-t3SHoVu8g

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #34

                              Hov, så må tallet - kongetallet om noget - være sivet. Ca 40% CR!

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #35

                                Major Shareholder Announcement Wellington Management Group LLP has informed us that, as of May 27, 2022, Wellington Management Group LLP through shares and financial instruments holds the voting rights 5.01% of the share capital and voting rights in Genmab A/S. https://www.globenewswire.com/news-release/2022/06/01/2454605/0/en/Major-Shareholder-Announcement.html

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #36

                                  Som de siger: Bedst i alle parametre.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #37

                                    Tak Mads

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #38

                                      we did not have that CR yet, did we?

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #39

                                        No it looks like abbvie has said it in an interview with bernstein

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #40

                                          Maybe it’s official tomorrow together with eha lba.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper